Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases
Tóm tắt
Từ khóa
Tài liệu tham khảo
AL Mammen, 2010, Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis., Ann N Y Acad Sci, 1184, 134, 10.1111/j.1749-6632.2009.05119.x
TP O'Hanlon, 2009, Genetic risk and protective factors for the idiopathic inflammatory myopathies., Curr Rheumatol Rep, 11, 287, 10.1007/s11926-009-0040-2
SA Greenberg, 2004, Uncertainties in the pathogenesis of adult dermatomyositis., Curr Opin Neurol, 17, 359, 10.1097/00019052-200406000-00018
K Arahata, 1984, Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells., Ann Neurol, 16, 193, 10.1002/ana.410160206
G Page, 2004, Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells., Arthritis Rheum, 50, 199, 10.1002/art.11428
B De Paepe, 2009, Role of cytokines and chemokines in idiopathic inflammatory myopathies., Curr Opin Rheumatol, 21, 610, 10.1097/BOR.0b013e3283317b31
SA Greenberg, 2010, Dermatomyositis and type 1 interferons., Curr Rheumatol Rep, 12, 198, 10.1007/s11926-010-0101-6
TB Niewold, 2009, Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy., Arthritis Rheum, 60, 1815, 10.1002/art.24555
EC Baechler, 2007, An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity., Mol Med, 13, 59, 10.2119/2006-00085.Baechler
RJ Walsh, 2007, Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis., Arthritis Rheum, 56, 3784, 10.1002/art.22928
AN Crowson, 1996, The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis., Hum Pathol, 27, 15, 10.1016/S0046-8177(96)90132-X
JM Mascaro Jr, 1995, Membrane attack complex deposits in cutaneous lesions of dermatomyositis., Arch Dermatol, 131, 1386, 10.1001/archderm.1995.01690240040007
CM Magro, 1997, The immunofluorescent profile of dermatomyositis: a comparative study with lupus erythematosus., J Cutan Pathol, 24, 543, 10.1111/j.1600-0560.1997.tb01458.x
J Wenzel, 2005, Evidence for a role of type I interferons in the pathogenesis of dermatomyositis., Br J Dermatol, 153, 462, 10.1111/j.1365-2133.2005.06786.x
J Wenzel, 2006, Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis., Clin Exp Dermatol, 31, 576, 10.1111/j.1365-2230.2006.02150.x
S Shrestha, 2010, Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells., Arthritis Rheum, 62, 2813, 10.1002/art.27529
JM McNiff, 2008, Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus., J Cutan Pathol, 35, 452, 10.1111/j.1600-0560.2007.00848.x
SA Greenberg, 2009, Similar topology of injury to keratinocytes and myofibres in dermatomyositis skin and muscle., Br J Dermatol, 160, 464, 10.1111/j.1365-2133.2008.08967.x
M Caproni, 2004, Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis., Br J Dermatol, 151, 784, 10.1111/j.1365-2133.2004.06144.x
AM Saaf, 2008, Global expression profiling in atopic eczema reveals reciprocal expression of inflammatory and lipid genes., PLoS One, 3, e4017, 10.1371/journal.pone.0004017
JE Gudjonsson, 2010, Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models., J Invest Dermatol, 130, 1829, 10.1038/jid.2010.36
SD Der, 1998, Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays., Proc Natl Acad Sci U S A, 95, 15623, 10.1073/pnas.95.26.15623
C Sanda, 2006, Differential gene induction by type I and type II interferons and their combination., J Interferon Cytokine Res, 26, 462, 10.1089/jir.2006.26.462
S Indraccolo, 2007, Identification of genes selectively regulated by IFNs in endothelial cells., J Immunol, 178, 1122, 10.4049/jimmunol.178.2.1122
JE Gudjonsson, 2009, Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin., J Invest Dermatol, 129, 2795, 10.1038/jid.2009.173
Y Yao, 2009, Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus., Arthritis Rheum, 60, 1785, 10.1002/art.24557
DA Plager, 2007, Early cutaneous gene transcription changes in adult atopic dermatitis and potential clinical implications., Exp Dermatol, 16, 28, 10.1111/j.1600-0625.2006.00504.x
SA Greenberg, 2005, Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis., Ann Neurol, 57, 664, 10.1002/ana.20464
Z Tezak, 2002, Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis., J Immunol, 168, 4154, 10.4049/jimmunol.168.8.4154
Y Yao, 2008, Type I interferon: potential therapeutic target for psoriasis?, PLoS One, 3, e2737, 10.1371/journal.pone.0002737
J Wenzel, 2008, An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in “interface dermatitis”., J Invest Dermatol, 128, 2392, 10.1038/jid.2008.96
M Ghoreishi, 2010, Type 1 interferon signature in the scalp lesions of alopecia areata., Br J Dermatol, 163, 57, 10.1111/j.1365-2133.2010.09775.x
RD Sontheimer, 2002, Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects., Dermatol Clin, 20, 387, 10.1016/S0733-8635(02)00021-9